Oral agent offers relief from generalized hyperhidrosis

Abstract

Hyperhidrosis is a common, self-limiting problem affecting 2% to 3% of the population in the United States. Patients may complain of localized sweating of the hands, feet, face, or underarms or more systemic, generalized sweating in multiple locations. Either way, patients always note a significant impact on their quality of life. Treatment of hyperhidrosis has traditionally focused on topical therapies to the affected areas. The availability of low-cost prescription and over-the-counter aluminum-based antiperspirant agents makes topicals the first-line choice.